Histological alterations in the liver of rats induced by different gold nanoparticle sizes, doses and exposure duration

Journal of Nanobiotechnology

Volumn 10, Issue , 2012, Pages

  Abdelhalim, Mohamed A K ^a   Jarrar, Bashir M ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b JOUF UNIVERSITY   (Saudi Arabia)

Author keywords

Gold nanoparticles; Hepatic tissue; Histology; Hydropic degeneration; Nanotoxicity; Rats; Size

Indexed keywords

GOLD NANOPARTICLES; HEPATIC TISSUE; HYDROPIC DEGENERATION; NANOTOXICITY; SIZE;

GOLD; HISTOLOGY; INDUSTRIAL APPLICATIONS; MEDICAL APPLICATIONS; RATS; TISSUE; TOXICITY;

NANOPARTICLES;

GOLD NANOPARTICLE; GOLD; METAL NANOPARTICLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CENTRAL VEIN; CONTROLLED STUDY; CYTOTOXICITY; HISTOCHEMISTRY; INFLAMMATORY CELL; INFUSION; LIVER; LIVER CELL; LIVER FATTY DEGENERATION; LIVER HILUS; LIVER HISTOLOGY; LIVER SINUSOID; LIVER TOXICITY; MALE; NONHUMAN; OXIDATIVE STRESS; PARTICLE SIZE; RAT; SWELLING; ANIMAL; CHEMICALLY INDUCED DISORDER; CHEMISTRY; CYTOPLASM; DRUG EFFECT; KUPFFER CELL; NECROSIS; PATHOLOGY; TOXICITY TESTING; WISTAR KYOTO RAT;

RATTUS;

ANIMALS; CYTOPLASM; GOLD; HEPATOCYTES; KUPFFER CELLS; LIVER; MALE; METAL NANOPARTICLES; NECROSIS; PARTICLE SIZE; RATS; RATS, INBRED WKY; TOXICITY TESTS;

EID: 84856082591     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/1477-3155-10-5     Document Type: Article

References (23)

1. Lanone S, Boczkowski J. Biomedical applications and potential health risks of nanomaterials: molecular mechanisms. Curr Mol Med 2006, 6:651-63. 10.2174/156652406778195026, 17022735.
2. Yu LE, Yung L-YL, Balasubramaniam KS, Hartono D, et al. Translocation and effects of gold nanoparticles after inhalation exposure in rats. Nanotoxicology 2007, 1(3):235-42.
3. Connor EE, Mwamuka J, Gole A, Murphy CJ, Wyatt MD. Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. Small 2005, 1(3):325-327. 10.1002/smll.200400093, 17193451.
4. Takahashi H, Niidome Y, Niidome T, Kaneko K, Kawasaki H, Yamada S. Modification of gold nanorods using phosphatidylcholineto reduce cytotoxicity. Langmuir 2006, 22(1):2-5. 10.1021/la0520029, 16378388.
5. Pan Y, Neuss S, Leifert A, Fischler M, Wen F, Simon U. Size-dependent cytotoxicity of gold nanoparticles. Small 2007, 3(11):1941-1949. 10.1002/smll.200700378, 17963284.
6. MacNee W, Donaldson K. Mechanism of lung injury caused by PM10 and ultrafine particles with special reference to COPD. Eur Respir J 2003, 21(40):47S-51S.
7. Jia HY, Liu Y, Zhang XJ, Han L, Du LB, Tian Q. Potential oxidative stress of gold Nanoparticles by induced-NO releasing in serum. J am Chem Soc 2009, 131(1):40-1. 10.1021/ja808033w, 19072650.
8. Chithrani BD, Chan WC. Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett 2007, 7:1542-1550. 10.1021/nl070363y, 17465586.
9. Pan Y, Neuss S, Leifert A, Fischler M, Wen F, Simon U, Schmid G, Brandau W, Jahnen-Dechent W. Size-dependent cytotoxicity of gold nanoparticles. Small 2007, 3:1941-1949. 10.1002/smll.200700378, 17963284.
10. BarathManiKanth S, Kalishwaralal K, Sriram M, Pandian SR, Youn H, Eom S, Gurunathan S. Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. Journal of Nanobiotechnology 2010, 8:16. 10.1186/1477-3155-8-16, 2914719, 20630072.
11. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL- 3A rat liver cells. Toxicol in Vitro 2005, 19:975-983. 10.1016/j.tiv.2005.06.034, 16125895.
12. Schrand AM, Bradich-Stolle LK, Schlager JJ, Dai L, Hussain SM. Can silver nanoparticles be useful as potential biological labels?. Nanotechnology 2008, 9:1-13.
13. Shaw SY, Westly EC, Pittet MJ, Subramanian A, Schreiber SL, Weissleder R. Perturbational profiling of nanomaterial biologic activity. Proc Natl Acad Sci USA 2008, 105:7387-7392. 10.1073/pnas.0802878105, 2396702, 18492802.
14. Gibson JD, Khanal BP, Zubarev ER. Paclitaxel-functionalized gold nanoparticles. J Am Chem Soc 2007, 129:11653-11661. 10.1021/ja075181k, 17718495.
15. Pearse AE. Histochemistry. Theoritical and applied. Analytical technology. 1985, 2. Churchill-Livingstone, Edinburgh, 4.
16. Del Monte U. Swelling of hepatocytes injured by oxidative stress suggests pathological changes related to macromolecular crowding. Medical Hypotheses 2005, 64(4):818-825. 10.1016/j.mehy.2004.08.028, 15694703.
17. Schrand AM, Rahman MF, Hussain SM, Schlager JJ, 1 David A, Smith DA, Syed2 AF. Metal-based nanoparticles and their toxicity assessment. Nanomed Nanobiotechnol 2010, 2:544-568.
18. Zusman I, Kozlenko M, Zimber A. Nuclear polymorphism and nuclear size in precarcinomatous and carcinomatous lesions in rat colon and liver. Cytometry 1991, 12(4):302-7. 10.1002/cyto.990120403, 2065554.
19. Gerlyng1 P, Åbyholm1 A, Grotmol T, Erikstein B, Huitfeldt HS, Stokke T, Seglen1 PO. Binucleation and polyploidization patterns in developmental and regenerative rat liver growth. Cell Proliferation 2008, 26(6):557-565.
20. Johar D, Roth JC, Bay GH, Walker JN, Kroczak TJ, Los M. Inflammatory response, reactive oxygen species, programmed (necrotic-like and apoptotic) cell death and cancer. Rocz Akad Med Bialymst 2004, 49:31-9.
21. Neyrinck A. Modulation of Kupffer cell activity: physio-pathological consequences on hepatic metabolism. Bull Mem Acad R Med Belg 2004, 159(5-6):358-66.
22. Reddy JK, Rao MS. Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol 2006, 290(5):G852-8.
23. Pandey G, Srivastava DN, Madhuri S. A standard hepatotoxic model produced by paracetamol in rat. Toxicology International 2008, 15(1):69-70.